COMPANY PROFILE:
Cell Well Ltd. is a supplier of cell-based products for pre-clinical screening, Hepatitis research, scientific investigation, cell research, drug design and discovery. We aim to provide state of art cell-based products for scientists and investigators worldwide for the purpose of accelerating and improving R&D process.
PRODUCT IN BRIEF:
The company’s offered HBV infection-sensitive human cells HHL(human hepatocyte-like cells) represent a novel sustainable model for conducting infection/neutralizing procedures, thereby serving as a new tool for antiviral drug and vaccine prototype screening and provide means for studying the viral-host interactions and viral entry and uncoating – the unknown steps of HBV life cycle.
LOCATION&FACILITIES:
Our office is located in Riga, Latvia (EU), 31 Cesu str., 7th building. The Company’s production and storage facilities are located in Latvian Biomedical Research and Study Center.
Product manufacturing is performed in accordance with EU standards and ISO 9001:2008, on BioSpherix stem cell workstation.
COLLABORATION IN R&D:
Cell Well Ltd. closely collaborates with Latvian Biomedical Research and Study Center (BMC) in means of products R&D. Latvian Biomedical Research and Study Center, with its 40 years of front-line experience in research of Hepatitis provides infection/neutralizing procedures, thus approving the sustainability and effectiveness of our company’s Hepatitis related products.
LEARN MORE: Cell Well Ltd. Company profile.